Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PCDHB15 | Human | 1,2-dichloroethane | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PCDHB15 mRNA | CTD | PMID:28960355 | PCDHB15 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PCDHB15 mRNA | CTD | PMID:22206623 | PCDHB15 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCDHB22 mRNA | CTD | PMID:21570461 and PMID:26377647 | PCDHB15 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCDHB22 mRNA | CTD | PMID:33387578 | PCDHB15 | Human | 2,4-diaminotoluene | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in decreased expression of PCDHB22 mRNA | CTD | PMID:20713471 | PCDHB15 | Human | 2,6-dinitrotoluene | affects expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of PCDHB22 mRNA | CTD | PMID:21346803 | PCDHB15 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | bisphenol S results in increased expression of PCDHB22 mRNA | CTD | PMID:30951980 | PCDHB15 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Pcdhb22 (Mus musculus) | 6480464 | bisphenol S affects the methylation of PCDHB15 gene | CTD | PMID:31683443 | PCDHB15 | Human | acrylamide | affects expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Acrylamide affects the expression of PCDHB22 mRNA | CTD | PMID:28959563 | PCDHB15 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of PCDHB15 protein | CTD | PMID:20106945 | PCDHB15 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PCDHB15 exon | CTD | PMID:30157460 | PCDHB15 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PCDHB15 gene | CTD | PMID:27153756 | PCDHB15 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PCDHB15 mRNA | CTD | PMID:22178795 | PCDHB15 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PCDHB15 promoter | CTD | PMID:27901495 | PCDHB15 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PCDHB15 exon | CTD | PMID:27901495 | PCDHB15 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter | CTD | PMID:23359474 | PCDHB15 | Human | bisphenol A | multiple interactions | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter | CTD | PMID:23359474 | PCDHB15 | Human | bisphenol A | decreases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PCDHB15 mRNA | CTD | PMID:25181051 | PCDHB15 | Human | bisphenol F | increases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PCDHB22 mRNA | CTD | PMID:30951980 | PCDHB15 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PCDHB15 gene] | CTD | PMID:28238834 | PCDHB15 | Human | chlorpyrifos | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PCDHB22 mRNA | CTD | PMID:37019170 | PCDHB15 | Human | choline | multiple interactions | ISO | Pcdhb22 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA | CTD | PMID:20938992 | PCDHB15 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PCDHB15 mRNA | CTD | PMID:27392435 | PCDHB15 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PCDHB15 mRNA | CTD | PMID:27392435 | PCDHB15 | Human | copper atom | increases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of PCDHB15 mRNA | CTD | PMID:26033743 | PCDHB15 | Human | copper(0) | increases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of PCDHB15 mRNA | CTD | PMID:26033743 | PCDHB15 | Human | dibutyl phthalate | multiple interactions | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PCDHB15 promoter | CTD | PMID:23359474 | PCDHB15 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA | CTD | PMID:27188386 | PCDHB15 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PCDHB15 mRNA | CTD | PMID:29803840 | PCDHB15 | Human | ethanol | increases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Ethanol results in increased expression of PCDHB15 mRNA | CTD | PMID:30319688 | PCDHB15 | Human | folic acid | multiple interactions | ISO | Pcdhb22 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA | CTD | PMID:20938992 | PCDHB15 | Human | folic acid | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PCDHB22 mRNA | CTD | PMID:25629700 | PCDHB15 | Human | gentamycin | decreases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PCDHB22 mRNA | CTD | PMID:33387578 | PCDHB15 | Human | L-methionine | multiple interactions | ISO | Pcdhb22 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB22 mRNA | CTD | PMID:20938992 | PCDHB15 | Human | lead(0) | affects methylation | EXP | | 6480464 | Lead affects the methylation of PCDHB15 gene | CTD | PMID:31636367 | PCDHB15 | Human | manganese(II) chloride | increases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of PCDHB22 mRNA | CTD | PMID:28801915 | PCDHB15 | Human | methotrexate | affects expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Methotrexate affects the expression of PCDHB15 mRNA and Methotrexate affects the expression of PCDHB22 mRNA | CTD | PMID:18502557 | PCDHB15 | Human | ozone | multiple interactions | ISO | Pcdhb22 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDHB22 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDHB22 mRNA | CTD | PMID:34911549 | PCDHB15 | Human | paracetamol | affects expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PCDHB22 mRNA | CTD | PMID:17562736 | PCDHB15 | Human | paracetamol | decreases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PCDHB22 mRNA | CTD | PMID:33387578 | PCDHB15 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of PCDHB15 mRNA | CTD | PMID:25812627 | PCDHB15 | Human | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of PCDHB15 mRNA | CTD | PMID:25812627 | PCDHB15 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of PCDHB15 mRNA | CTD | PMID:25812627 | PCDHB15 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA | CTD | PMID:27188386 | PCDHB15 | Human | sodium fluoride | increases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of PCDHB15 mRNA | CTD | PMID:27862939 | PCDHB15 | Human | sodium fluoride | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of PCDHB22 mRNA | CTD | PMID:27862939 | PCDHB15 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of PCDHB15 mRNA | CTD | PMID:31533062 | PCDHB15 | Human | trichloroethene | decreases expression | ISO | Pcdhb22 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of PCDHB22 mRNA | CTD | PMID:33387578 | PCDHB15 | Human | triptonide | decreases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | triptonide results in decreased expression of PCDHB15 mRNA and triptonide results in decreased expression of PCDHB22 mRNA | CTD | PMID:33045310 | PCDHB15 | Human | trovafloxacin | increases expression | ISO | Pcdhb22 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of PCDHB22 mRNA | CTD | PMID:35537566 | PCDHB15 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PCDHB15 mRNA | CTD | PMID:25979313 | PCDHB15 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PCDHB15 mRNA | CTD | PMID:23179753 and PMID:26272509 | PCDHB15 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB15 mRNA | CTD | PMID:27188386 | |